Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by rfk67on Jul 18, 2008 1:45am
356 Views
Post# 15305384

RE: Similiar stage, totally different stock price?

RE: Similiar stage, totally different stock price?You say "we" as if you own the stock yet you also ask leading questions that say in effect there's something wrong here.  You reject the "biotech out of favor" theory because of Cardiome yet fail to account for BioMs and you have quite the negative tone for a long.  Assuming that you do own ISA II suggest that you sell, and remember I'm the guy who tried to get antoninus out of this thing way back when. 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities